| scholarly article | Q13442814 |
| P2093 | author name string | Yan Yu | |
| Xiaodong Xu | |||
| Pengwei Lv | |||
| Ke Zong | |||
| Yuantin Gu | |||
| P2860 | cites work | Cancer statistics, 2016 | Q29547383 |
| Systematic review of outcomes after distal pancreatectomy with coeliac axis resection for locally advanced pancreatic cancer. | Q30249609 | ||
| Imp2 regulates GBM progression by activating IGF2/PI3K/Akt pathway | Q36214062 | ||
| Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model | Q36545604 | ||
| Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? | Q37002361 | ||
| IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes | Q37476395 | ||
| Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin | Q37690896 | ||
| Local recurrence of pancreatic cancer after primary surgical intervention: how to deal with this devastating scenario? | Q37875981 | ||
| IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype. | Q40478066 | ||
| IGF2 mRNA binding protein-2 is a tumor promoter that drives cancer proliferation through its client mRNAs IGF2 and HMGA1 | Q41559661 | ||
| Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature | Q42695251 | ||
| IGFBP2 Activates the NF-κB Pathway to Drive Epithelial-Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma | Q43990089 | ||
| IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer. | Q46256483 | ||
| Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer | Q47146670 | ||
| VICKZ2 protein expression in ovarian serous carcinoma effusions is associated with poor survival. | Q50663650 | ||
| ELF3 promotes epithelial-mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma. | Q52663603 | ||
| SOX9 regulates ERBB signalling in pancreatic cancer development. | Q53229089 | ||
| MicroRNA-141 inhibits proliferation of gastric cardia adenocarcinoma by targeting MACC1. | Q53681668 | ||
| Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4. | Q55517744 | ||
| CPNE1 is a target of miR-335-5p and plays an important role in the pathogenesis of non-small cell lung cancer. | Q55517974 | ||
| WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC | Q90448068 | ||
| Regulation of tumor angiogenesis by microRNAs: State of the art | Q90709815 | ||
| Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19 | Q90791080 | ||
| miR-141-3p is a key negative regulator of the EGFR pathway in osteosarcoma | Q90929939 | ||
| The Insulin-Like Growth Factor 2 mRNA Binding Protein IMP2/IGF2BP2 is Overexpressed and Correlates with Poor Survival in Pancreatic Cancer | Q91519705 | ||
| P433 | issue | 1 | |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 497 | |
| P577 | publication date | 2019-12-18 | |
| P1433 | published in | Journal of Experimental & Clinical Cancer Research | Q13739415 |
| P1476 | title | Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway | |
| P478 | volume | 38 |
| Q94547481 | Clinical Significance of an m6A Reader Gene, IGF2BP2, in Head and Neck Squamous Cell Carcinoma |
| Q96231220 | Identification and validation of m6A RNA methylation regulators with clinical prognostic value in Papillary thyroid cancer |
| Q98770571 | Important players in carcinogenesis as potential targets in cancer therapy: an update |
| Q99551787 | MicroRNA-23b-3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF-κB signaling pathways |
| Q91790678 | Modulator-Dependent RBPs Changes Alternative Splicing Outcomes in Kidney Cancer |
| Q100490609 | Overview of current targeted therapy in gallbladder cancer |
Search more.